News

23/2/2018

Adolescents want to be taken seriously in sexual and reproductive health care

Sexual health is still taboo in many African countries. So how can we transform health care in such a way that adolescents can benefit from this care as best as possible? Read more

Blog

22/2/2018

A global gathering for UHC

In December 2017, the Global Forum for Universal Health Coverage (UHC) took place in Tokyo. Global health advocate Barbara Fienieg represented Wemos at the conference. We asked her about her impressions. Read more

Truck driving/ Vrchtwagen aan het rijden

Blog

12/2/2018

Reaching parts that other can’t?

There is uproar in global health circles. The Global Fund to fight AIDS, Tuberculosis and Malaria and Dutch beer brewer HEINEKEN have entered into a partnership Read more

News

19/1/2018

Ema and big pharma: conflict of interests or not?

Can the European Medicines Agency (EMA) be truly independent, if it also is in close contact with the pharmaceutical industry? Read more

Blog

17/1/2018

‘Recruiting health workers from Africa? Just plain unacceptable.’

Last week, Wemos’ global health advocate Linda Mans shared her knowledge of the migration and mobility of health workers with global health students during two workshops at the University of Groningen. Read more

News

12/1/2018

No ban on BPA in food contact materials

There will be no European ban on the endocrine-disrupting chemical Bisphenol A (BPA). The European Parliament has voted that BPA will remain in food contact materials. Wemos regrets that European citizens will therefore remain exposed to this harmful substance. Read more

News

4/1/2018

The long arm of the pharmaceutical industry

How does the pharmaceutical industry influence the European Medicines Agency? Can the organization independently carry out its work? Read more

Blog

2/1/2018

Why future African doctors in training should become lobbyists

The lack of health professionals worldwide is estimated around 18 million in 2030, especially in low- and middle-income countries. Read more

News

12/12/2017

Why EMA can do more for clinical trial subjects

Malpractices in clinical trials are still common. In October, three Members of the European Parliament requested the European Medicines Agency to address these issues. The agency’s reply to the letter still leaves Wemos concerned. Read more